Akebia Therapeutics AKBA
NASDAQ AKBA
$0.87 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Return on Invested Capital [ROIC] (2020 - 2026)

Updated

Akebia Therapeutics' Return on Invested Capital [ROIC] came in at -20.05% for Q2 2026, down 26.79 percentage points from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Return on Invested Capital [ROIC] (2020 - 2026) Analysis & Trends

For FY2025, Akebia Therapeutics' Return on Invested Capital [ROIC] was 66.79%.

  • The Q2 2026 figure represents the lowest quarterly Return on Invested Capital [ROIC] since Q3 2020.
  • Business Quant data shows AKBA's Return on Invested Capital [ROIC] at 6.73% (Q1 2026), 27.63% (Q4 2025) and 21.44% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Akebia Therapeutics 236.42 Mn -433.06 Mn 38.70 Mn -20.05%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.05%
Mar 31, 2026 6.73%
Dec 31, 2025 27.63%
Sep 30, 2025 21.44%
Sep 30, 2020 -91.35%
Jun 30, 2020 -82.86%
Mar 31, 2020 -56.44%
API Access

Akebia Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=AKBA&period=max&api_key=YOUR_API_KEY